ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,779 | -$13,212 | -$18,062 | -$9,399 |
| Dep. & Amort. | $0 | $21 | $11 | $46 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $826 | $272 | $488 | $0 |
| Change in WC | -$11,730 | $2,945 | $5,403 | -$1,586 |
| Other Non-Cash | -$19,057 | -$869 | -$4,873 | $1,497 |
| Operating Cash Flow | -$27,182 | -$10,844 | -$17,034 | -$9,442 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$2 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $100 |
| Inv. Purchases | -$33 | -$32 | -$31 | -$34 |
| Inv. Sales/Matur. | $32 | $31 | $31 | $36 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$1 | -$2 | $96 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $27,848 | $17,745 | $4,974 | $25,630 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28 | $4 | $1,520 | $0 |
| Financing Cash Flow | $27,876 | $17,749 | $6,495 | $25,630 |
| Forex Effect | $0 | -$181 | -$527 | -$114 |
| Net Chg. in Cash | $693 | $6,722 | -$11,068 | $16,169 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,598 | $5,876 | $16,944 | $808 |
| End Cash | $13,291 | $12,598 | $5,876 | $16,977 |
| Free Cash Flow | -$27,182 | -$10,844 | -$17,036 | -$9,448 |